RECRUITING

Retrospective Review of Esophageal Cancer at MSKCC

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Residual tumor at the proximal or distal margin after esophagectomy is a known prognostic factor for poor survival outcomes in patients with esophageal cancer; however, the significance of the circumferential resection margin (CRM) remains controversial. In this study, the investigators sought to evaluate the prognostic significance of the CRM in patients with esophageal cancer undergoing resection.

Official Title

Retrospective Review of Esophageal Cancer at MSKCC

Quick Facts

Study Start:2016-12-13
Study Completion:2025-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05706558

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Histologically confirmed esophageal adenocarcinoma (EAC) or esophageal squamous cell carcinoma (ESCC) undergoing esophagectomy
  2. * Pathologic staged T3 tumors (pT3)
  1. * Pathologic staged T0-2 (pT0-2) or T4 tumors (pT4)
  2. * Patients with histologic types other than EAC or ESCC, dysplasia or carcinoma in situ without tumor invasion,
  3. * Patients undergoing salvage esophagectomy
  4. * Evidence of distant metastatic disease
  5. * Patients with a positive proximal or distal margin

Contacts and Locations

Study Contact

Daniela Molena, MD
CONTACT
212-639-3870
molenad@mskcc.org
James Isbell, MD
CONTACT
212-639-6247
isbellj@mskcc.org

Principal Investigator

Daniela Molena, MD
PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center

Study Locations (Sites)

Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065
United States

Collaborators and Investigators

Sponsor: Memorial Sloan Kettering Cancer Center

  • Daniela Molena, MD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2016-12-13
Study Completion Date2025-02

Study Record Updates

Study Start Date2016-12-13
Study Completion Date2025-02

Terms related to this study

Keywords Provided by Researchers

  • Esophageal Cancer
  • Esophagus Cancer
  • Memorial Sloan Kettering Cancer Center
  • 16-1631

Additional Relevant MeSH Terms

  • Esophageal Cancer
  • Esophagus Cancer